Hosoi, Hiroki http://orcid.org/0000-0002-8682-7476
Tanigawa, Ikuro
Kosako, Hideki
Okamoto, Akinao
Iwamoto, Ryuta
Koh, Jinsoo
Mori, Megumi
Hiroi, Takayuki
Mushino, Toshiki
Murata, Shogo
Tamura, Shinobu
Murata, Shin-Ichi
Tomita, Akihiro
Sonoki, Takashi
Article History
Received: 25 May 2021
Accepted: 4 June 2021
First Online: 3 July 2021
Declarations
:
: This study was approved by the ethics committee of Wakayama Medical University (No. 2919). All procedures performed in studies involving human participants were carried out in accordance with the ethical standards of the relevant institutional and/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from the patient.
: Akihiro Tomita received lecture fee from Chugai Pharmaceutical, Takeda Pharmaceutical, and research fund from Perseus Proteomics Inc, Novartis Phama K.K., Pfizer Japan Inc, Chugai Pharmaceutical, Kyowa Kirin, Ono Pharmaceutical, Taiho Pharmaceutical. The other authors declare that they have no conflicts of interest.